Profiling of tumour-associated microbiota in human hepatocellular carcinoma

[1]  Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.

[2]  Noam Shental,et al.  The human tumor microbiome is composed of tumor type–specific intracellular bacteria , 2020, Science.

[3]  Q. Ou,et al.  Gut microbiota dysbiosis in patients with hepatitis B virus–induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma , 2020, Journal of viral hepatitis.

[4]  R. Bataller,et al.  Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease , 2019, Nature.

[5]  Chenchen Xie,et al.  Hepatocellular carcinoma in alcoholic and non-alcoholic fatty liver disease-one of a kind or two different enemies? , 2019, Translational gastroenterology and hepatology.

[6]  Christine B. Peterson,et al.  Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes , 2019, Cell.

[7]  H. Vlamakis,et al.  Ruminococcus gnavus, a member of the human gut microbiome associated with Crohn’s disease, produces an inflammatory polysaccharide , 2019, Proceedings of the National Academy of Sciences.

[8]  Yewei Zhang,et al.  Alteration in gut microbiota associated with hepatitis B and non-hepatitis virus related hepatocellular carcinoma , 2019, Gut Pathogens.

[9]  Lixin Wei,et al.  Tumor necrosis factor-α promotes hepatocellular carcinogenesis through the activation of hepatic progenitor cells. , 2018, Cancer letters.

[10]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[11]  H. Yoshiji,et al.  Gut Dysbiosis Associated With Hepatitis C Virus Infection , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  Eric C. Polley,et al.  Interaction between the microbiome and TP53 in human lung cancer , 2018, Genome Biology.

[13]  A. Gasbarrini,et al.  Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease , 2018, Hepatology.

[14]  Tian Tian,et al.  Distinct Microbial Signatures Associated With Different Breast Cancer Types , 2018, Front. Microbiol..

[15]  Justine W. Debelius,et al.  The gut–liver axis and the intersection with the microbiome , 2018, Nature Reviews Gastroenterology & Hepatology.

[16]  Donna Neuberg,et al.  Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer , 2017, Science.

[17]  Menghui Zhang,et al.  Gut Microbial Dysbiosis Is Associated with Altered Hepatic Functions and Serum Metabolites in Chronic Hepatitis B Patients , 2017, Front. Microbiol..

[18]  Pelin Yilmaz,et al.  25 years of serving the community with ribosomal RNA gene reference databases and tools. , 2017, Journal of biotechnology.

[19]  M. Yassour,et al.  A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients , 2017, Genome Medicine.

[20]  Noam Shental,et al.  Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine , 2017, Science.

[21]  R. Schwabe,et al.  The gut microbiome and liver cancer: mechanisms and clinical translation , 2017, Nature Reviews Gastroenterology &Hepatology.

[22]  Shibu Yooseph,et al.  Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease. , 2017, Cell metabolism.

[23]  Zhi Wei,et al.  The ovarian cancer oncobiome , 2017, Oncotarget.

[24]  G. Gloor,et al.  The Microbiota of Breast Tissue and Its Association with Breast Cancer , 2016, Applied and Environmental Microbiology.

[25]  Lawrence A. David,et al.  The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota , 2016, Hepatology.

[26]  K. Hayashi,et al.  DSS colitis promotes tumorigenesis and fibrogenesis in a choline-deficient high-fat diet-induced NASH mouse model. , 2016, Biochemical and biophysical research communications.

[27]  Jean M. Macklaim,et al.  Microbiota of Human Breast Tissue , 2014, Applied and Environmental Microbiology.

[28]  Pelin Yilmaz,et al.  The SILVA and “All-species Living Tree Project (LTP)” taxonomic frameworks , 2013, Nucleic Acids Res..

[29]  M. Meyerson,et al.  Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. , 2013, Cell host & microbe.

[30]  Pelin Yilmaz,et al.  The SILVA ribosomal RNA gene database project: improved data processing and web-based tools , 2012, Nucleic Acids Res..

[31]  H. El‐Serag,et al.  Epidemiology of viral hepatitis and hepatocellular carcinoma. , 2012, Gastroenterology.

[32]  Raul Rabadan,et al.  Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. , 2012, Cancer cell.

[33]  C. Huttenhower,et al.  Metagenomic biomarker discovery and explanation , 2011, Genome Biology.

[34]  P. Bork,et al.  Enterotypes of the human gut microbiome , 2011, Nature.

[35]  Anders F. Andersson,et al.  A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. , 2010, Gastroenterology.

[36]  Guan-Tarn Huang,et al.  Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. , 2006, JAMA.

[37]  S. D. Lee,et al.  Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation. , 1995, Journal of hepatology.

[38]  S. Orsulic,et al.  Ovarian Cancer , 1993, British Journal of Cancer.

[39]  M. Kawahara,et al.  Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease , 2017, Journal of Gastroenterology.

[40]  F. Bishehsari,et al.  Alcohol and Gut-Derived Inflammation , 2017, Alcohol research : current reviews.

[41]  P. Loehrer,et al.  Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level , 2007 .